Börsipäev 14. juuni - Investment topic - Forum - LHV financial portal

LHV financial portal

Forum Investment topic

Börsipäev 14. juuni

Log in or create an account to leave a comment

  • Allasuunas ei suutnud tehnoloogiasektor S&P 500 indeksit kaasa tirida, küll aga liiguti eile käsikäes ülespoole, mis tähendas laiapõhjalise indeksi jaoks uut rekordit (+0,5%). Sentimendi paranemine tehnoloogiasektoris aitas ka Euroopas Stoxx 600 indeksil 0,6% kõrgemal sulguda.

    Öösel avaldatud Hiina majandusnäitajad jäid maikuus üldiselt stabiilseks, kui jaemüügi aastane kasvutempo püsis 10,7% peal (oodati 10,7%), tööstustoodang püsis 6,5% peal (oodati 6,4%) ning investeeringud fikseeritud varadesse aeglustusid viie kuu lõikes 8,9% pealt 8,6%le (oodati 8,8%). Eeltoodu baasil kasvas Bloombergi mudeli kohaselt Hiina SKP maikuus mullusega võrreldes 7,14%, ühtides aprillikuu tempoga.



    Peamine tähelepanu koondub täna FOMC intressimäära otsusele, keskpanga uutele majandusprognoosidele ning Janet Yelleni pressikonverentsile. Selle eel jõutakse veel seedida USA maikuu jaemüügi ning inflatsiooni statistikat.

    12.00 Eurotsooni tööstustoodang (aprill)
    11.30 Suurbritannia tööturu statistika (aprill/mai)
    15.30 USA inflatsioon (mai)
    15.30 USA jaemüük (mai)
    21.00 FOMC intressimäära otsus
    21.30 Janet Yelleni esinemine
  • Suurbritannia töötuse määr püsis aprillis 4,6% peal, palgakasv aeglustus boonuseid arvestamata 1,7%le (oodati 2,0%), mis eilse inflatisooni taustal tähendab juba reaalse sissetuleku langust
  • Euroala tööstustoodang kasvas aprillis MoM ootuspärased 0,5%, kuid seda tugevamaks revideeritud märtsi kasvu pealt (-0,1% asemel 0,2%). Mullusega võrreldes kasvas toodang samuti ootuspärased 1,4%.
  • Uute laenude maht kasvas Hiinas eelmisel kuul oodatud 1,0 triljoni jüaani asemel 1,11 triljoni võrra. Agregeeritud finantseerimine oli 1,06 triljonit vs oodatud 1,19 triljonit jüaani

  • Reports of shooting at congressional baseball practice in VA; suspect believed to be in custody
    House Majority Whip Steve Scalise, aides shot at baseball practice in Virginia, Fox News confirm
  • GERMANY'S DAX .GDAXI HITS RECORD HIGH, NOW UP 1.1 PCT
  • UPGRADES:
    * Fibria (FIBR3 BZ) raised to overweight at JPMorgan, PT $13.50
    * HCP (HCP) raised to outperform at Raymond James, PT $35
    * Neuroderm (NDRM) raised to outperform at Oppenheimer, PT $42
    * Oneok Inc (OKE) raised to buy at UBS, PT $59
    * Restaurant Brands (QSR CN) raised to outperform at Oppenheimer, PT $70
    * WNS Holdings (WNS) raised to outperform at Cowen
    * Waddell & Reed (WDR) raised to market perform at KBW, PT$17.75

    DOWNGRADES:
    * Anadarko (APC) cut to underweight at Barclays, PT $42
    * BRP Inc (DOO CN) cut to market perform at Wells Fargo, PT C$41
    * Carlisle (CSL) cut to market perform at Oppenheimer
    * First Connecticut Banc (FBNK) cut to neutral at Piper Jaffray
    * HD Supply (HDS) cut to neutral at Susquehanna, PT $33
    * Hawaiian Holdings (HA) cut to sell at Stifel, PT $40
    * Microsemi (MSCC) cut to outperform at RBC, PT $58
    * Starbucks (SBUX) cut to neutral at Wedbush
    * Synchronoss (SNCR) cut to hold at Drexel Hamilton

    INITIATIONS:
    * 1-800-Flowers (FLWS) new neutral at DA Davidson, PT $11
    * Callaway Golf (ELY) new market perform at Cowen, PT $14
    * FTD (FTD) new buy at DA Davidson, PT $23
    * Floor & Decor (FND) new neutral at Wedbush, PT $45
    * Gladstone Investment (GAIN) new outperform at Wedbush, PT $10
    * HMS Holdings (HMSY) new overweight at Cantor, PT $23
    * Janus Henderson (HGG LN) new overweight at Morgan Stanley
    * Lithia Motors (LAD) new neutral at Seaport Global
    * MedReleaf (LEAF CN) new outperform at Cowen, PT C$11
    * Netease (NTES) new hold at Hua Tai Securities, PT $339.05
    * Seacor Marine (SMHI) new in line at Evercore ISI, PT $20
    * Sina (SINA) new buy at Hua Tai Securities, PT $115.35
    * Ulta Beauty (ULTA) new neutral at Guggenheim
    * Vipshop Holdings (VIPS) new buy at Hua Tai Securities, PT $16.12
  • Gapping up
    In reaction to strong earnings/guidance:

    HRB +10.2%, BTI +0.8%, CPST +0.7%, CCE +0.7%, (reaffirmed outlook)
    M&A news:
    BKD +11.2% (Zhonghong Zhuoye Group is getting closer to deal to acquire BKD, according to FT)
    Other news:
    MBOT +12.8% (granted U.S. patent which covers a device for the prevention of shunt stenosis)
    SOL +7.9% (received a prelim proposal from Chairman and CEO Xianshou Li to acquire the co's manufacturing and LED distribution businesses and assume related indebtedness)
    ABIL +7.9% (stock continues to be volatile in pre-mkt activity)
    MVIS +7.1% (Microvision terminates at-the-market facility with IFS Securities)
    ALXN +4.5% (confirms it named BIIB's CFO Paul Clancy as its CFO effective July 31)
    BTX +3.8% (reports that, based on the analysis of top line data, the Renevia pivotal trial in Europe has met its primary endpoint)
    BLFS +3.5% (enters into a a supply agreement w/ Adaptimmune Therapeutics (ADAP))
    GNMK +2.2% (prices 6,382,978 shares of its common stock at $11.75 per share)
    EMR +0.9% (favorable commentary on last night's Mad Money)
    TSLA +0.9% (continued strength)
    WDC +0.9% (continued strength)
    Analyst comments:
    NDRM +4.4% (upgraded to Outperform from Perform at Oppenheimer)
    QSR +1.1% (upgraded to Outperform from Perform at Oppenheimer)
    NVDA +0.7% (target raised to $171 from $165 at Goldman)
    MU +0.5% (Credit Suisse sees upside for May and August quarters)
    Gapping down
    In reaction to disappointing earnings/guidance:

    BPMX -7.7%, TAX -5%, LEJU -2.1%
    Other news:
    ALDX -25.5% (light volume; to host a conference call and webcast on Wednesday, June 14, 2017 at 8:00 A.M. EDT to discuss results from its Phase 2b Allergic Conjunctivitis Trial)
    SQNS -5.7% (to offer newly issued American Depositary Shares, representing ordinary shares, in an underwritten public offering)
    WLL -2.8% (pulling back after closing near highs)
    MRO -2% (following API data and IEA report)
    SNCR -1.9% (light volume; independent registered public accounting firm concluded that previously issued financial statements for 2015/2016 fiscal years and the respective quarterly periods should be restated and should no longer be relied upon)
    KMDA -1.9% (slightly pulling back following recent strength in stock)
    BIIB -1.5% (CFO Paul Clancy to depart)
    Analyst comments:
    HA -3.7% (downgraded to Sell at Stifel)
    FIVE -0.8% (downgraded to Sector Weight from Overweight at KeyBanc Capital Mkts)
    SBUX -0.8% (downgraded to Neutral from Outperform at Wedbush)
    APC -0.5% (downgraded to Underweight from Equal Weight at Barclays)

    Briefing.com
  • USA inflatsioon aeglustus mais kütust ja toitu arvestamata -0,2pp võrra 1,7%le (oodati 1,9%), viidates ka FEDi poolt jälgitava inflatsioonimõõdiku edasisele aeglustumisele (aprillis 1,5%).
  • USA jaemüük püsis mais kütust ja toitu arvestamata MoM muutumatuna (oodati 0,3%), kuigi seda aitas kompenseerida aprilli kasv revideerimine 0,3% pealt 0,5%le
  • USA keskpank tõstab ootuspäraselt intressimäära, toob tänavust inflatsiooniootust alla, aga näeb endiselt veel ühte intressimäära tõstmist sel aastal ning kolme kergitamist tuleval aastal. Alustab tänavu (kuid ei täpsusta, mis kuul) bilansi vähendamist 10 miljardi dollari võrra kuus, mis jääb analüütikute ootuste vahemikku,

    FOMC increases target federal funds rate range by 25 basis points to 1.00% - 1.25%, as expected.
    Fed: 2017 GDP Growth Seen At 2.2% (Prev 2.1%), Unemployment Rate 4.3% (Prev 4.5%), Core Inflation 1.7% (Prev 1.9%)
    Fed: 2018 GDP Growth Seen At 2.1% (Prev 2.1%), Unemployment Rate 4.2% (Prev 4.5%), Core Inflation 2.0% (Prev 2.0%)
    Fed: Median View Of Appropriate Fed Funds Rate At End-2017 1.375% (Prev 1.375%)
    Fed: Median View Of Appropriate Fed Funds Rate At End-2018 2.125 (Prev 2.125%)
    SAYS BALANCE-SHEET ROLLOFF CAPS WOULD START AT $10 B/MONTH


    Parsing the Fed: How the June Statement Changed From May

Threads list

Cookies

LHV website uses cookies to provide you with the best user experience. By clicking "I accept", you consent to the use of all cookies. Read more about the principles of using cookies.

pirukas_icon